Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-08

FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for dorzolamide hydrochloride from Sagent Pharmaceuticals, authorizing this generic drug for lowering intraocular pressu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride (dorzolamide hydrochloride)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE (DORZOLAMIDE HYDROCHLORIDE)